Cargando…

Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury

OBJECTIVE: To identify the potential pharmacological targets of Jisuikang (JSK) for the treatment of spinal cord injury (SCI) using network pharmacology. METHODS: The bioactive compounds of JSK herbs and their corresponding potential SCI targets were obtained from three traditional Chinese medicine...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shaoshuo, Shao, Yang, Chen, Hao, Wang, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898796/
https://www.ncbi.nlm.nih.gov/pubmed/35265147
http://dx.doi.org/10.1155/2022/4932153
_version_ 1784663746732359680
author Li, Shaoshuo
Shao, Yang
Chen, Hao
Wang, Jianwei
author_facet Li, Shaoshuo
Shao, Yang
Chen, Hao
Wang, Jianwei
author_sort Li, Shaoshuo
collection PubMed
description OBJECTIVE: To identify the potential pharmacological targets of Jisuikang (JSK) for the treatment of spinal cord injury (SCI) using network pharmacology. METHODS: The bioactive compounds of JSK herbs and their corresponding potential SCI targets were obtained from three traditional Chinese medicine (TCM) databases. SCI-related therapeutic target genes were obtained from the Comparative Toxicogenomics Database and the GeneCards Database. The common target genes between the JSK compounds and SCI-related therapeutic targets were screened using GO/KEGG functional enrichment and protein-protein interaction (PPI) analyses to identify hub genes and their categories of biological function. Gene expression distribution and receiver operating characteristic curve (ROC) analyses were used to identify probable SCI-related target genes. Molecular docking was used to quantify molecular interactions between target genes and the bioactive compounds of JSK. RESULTS: A total of 183 JSK bioactive compounds and 197 target genes for the treatment of SCI were screened and assessed. The target genes were enriched primarily in drug metabolism and in inflammation-related biological processes. Ten genes with statistical significance were identified as therapeutic SCI-related target genes of JSK. Molecular docking experiments demonstrated that the proteins of these 10 genes docked with binding energies of less than −5 kcal/mol with the bioactive compounds in JSK. CONCLUSION: This study showed that the anti-SCI effects of JSK may be mediated through numerous bioactive components, multiple gene targets, and inflammation-related pathways and provided potential novel targets for directed therapies for treating SCI. These results provide a foundation for further experimental investigations into treatment options for SCI.
format Online
Article
Text
id pubmed-8898796
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-88987962022-03-08 Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury Li, Shaoshuo Shao, Yang Chen, Hao Wang, Jianwei Evid Based Complement Alternat Med Research Article OBJECTIVE: To identify the potential pharmacological targets of Jisuikang (JSK) for the treatment of spinal cord injury (SCI) using network pharmacology. METHODS: The bioactive compounds of JSK herbs and their corresponding potential SCI targets were obtained from three traditional Chinese medicine (TCM) databases. SCI-related therapeutic target genes were obtained from the Comparative Toxicogenomics Database and the GeneCards Database. The common target genes between the JSK compounds and SCI-related therapeutic targets were screened using GO/KEGG functional enrichment and protein-protein interaction (PPI) analyses to identify hub genes and their categories of biological function. Gene expression distribution and receiver operating characteristic curve (ROC) analyses were used to identify probable SCI-related target genes. Molecular docking was used to quantify molecular interactions between target genes and the bioactive compounds of JSK. RESULTS: A total of 183 JSK bioactive compounds and 197 target genes for the treatment of SCI were screened and assessed. The target genes were enriched primarily in drug metabolism and in inflammation-related biological processes. Ten genes with statistical significance were identified as therapeutic SCI-related target genes of JSK. Molecular docking experiments demonstrated that the proteins of these 10 genes docked with binding energies of less than −5 kcal/mol with the bioactive compounds in JSK. CONCLUSION: This study showed that the anti-SCI effects of JSK may be mediated through numerous bioactive components, multiple gene targets, and inflammation-related pathways and provided potential novel targets for directed therapies for treating SCI. These results provide a foundation for further experimental investigations into treatment options for SCI. Hindawi 2022-02-27 /pmc/articles/PMC8898796/ /pubmed/35265147 http://dx.doi.org/10.1155/2022/4932153 Text en Copyright © 2022 Shaoshuo Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Shaoshuo
Shao, Yang
Chen, Hao
Wang, Jianwei
Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
title Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
title_full Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
title_fullStr Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
title_full_unstemmed Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
title_short Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
title_sort using network pharmacology to systematically decipher the potential mechanisms of jisuikang in the treatment of spinal cord injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898796/
https://www.ncbi.nlm.nih.gov/pubmed/35265147
http://dx.doi.org/10.1155/2022/4932153
work_keys_str_mv AT lishaoshuo usingnetworkpharmacologytosystematicallydecipherthepotentialmechanismsofjisuikanginthetreatmentofspinalcordinjury
AT shaoyang usingnetworkpharmacologytosystematicallydecipherthepotentialmechanismsofjisuikanginthetreatmentofspinalcordinjury
AT chenhao usingnetworkpharmacologytosystematicallydecipherthepotentialmechanismsofjisuikanginthetreatmentofspinalcordinjury
AT wangjianwei usingnetworkpharmacologytosystematicallydecipherthepotentialmechanismsofjisuikanginthetreatmentofspinalcordinjury